Breaking News Instant updates and real-time market news.

JAZZ

Jazz Pharmaceuticals

$122.56

0.65 (0.53%)

06:29
10/05/16
10/05
06:29
10/05/16
06:29

Jazz risk/reward 'very favorable' at current levels, says BMO Capital

After hosting meetings with management, BMO Capital analyst Gary Nachman views the risk/reward as "very favorable" for shares of Jazz Pharmaceuticals. The analyst remains optimistic that a favorable Xyrem settlement would "lift a significant overhang" on shares and "help unlock untapped value with the pipeline." He reiterates an Outperform rating on Jazz with a $195 price target.

JAZZ Jazz Pharmaceuticals
$122.56

0.65 (0.53%)

07/28/16
WELS
07/28/16
NO CHANGE
WELS
Outperform
Jazz patent ruling a 'strong positive' for Xyrem durability, says Wells Fargo
Wells Fargo analyst David Maris noted that U.S. Patent Office's Patent Trial and Appeal Board decided not to institute an inter partes review Jazz's 8,772,306 patent covering Xyrem, which he views as a strong positive for the durability of the franchise. Maris, who said the PTAB decision supports his belief that generic filers will face several significant challenges in their attempts to invalidate Xyrem's patent protection, keeps an Outperform rating on Jazz shares.
07/28/16
COWN
07/28/16
NO CHANGE
Target $190
COWN
Outperform
Cowen recommends continuing to add to Jazz positions after IPR decision
Cowen analyst Ken Cacciatore noted that he has long considered Jazz's 8,772,306 patent as the "most critical component protecting the Xyrem franchise" and he believes that Amneal being denied its request to institute an inter partes review of the patent provides additional comfort. The analyst, who thinks that this decision sets the stage for Jazz and the remaining generic challengers to reach a settlement, recommends investors continue adding to Jazz positions. Cacciatore has a $190 price target and Outperform rating on Jazz shares.
08/25/16
JANY
08/25/16
INITIATION
JANY
Neutral
Jazz Pharmaceuticals initiated with a Neutral at Janney Capital
Janney Capital analyst Ken Trbovich started Jazz Pharmaceuticals with a Neutral rating and $145 fair value estimate, saying that Xyrem faces challenges from both branded competition and generics and he expects muted growth until Vyxeos is approved and launched in the second half of the next fiscal year.
09/26/16
JPMS
09/26/16
NO CHANGE
Target $205
JPMS
Overweight
Jazz pullback creates attractive entry point, says JPMorgan
JPMorgan analyst Jessica Fye believes the recent selloff in shares of Jazz Pharmaceuticals creates an attractive entry point for investors with a greater than three month time horizon. The analyst sees a "strong probability of success" for the JZP-110 Phase III data in early 2017 and believes the company's acquisition of Celator should help reduce the reliance on Xyrem, particularly post-2020. Fye keeps an Overweight rating on Jazz with a $205 price target.

TODAY'S FREE FLY STORIES

MRSN

Mersana Therapeutics

21:10
06/27/17
06/27
21:10
06/27/17
21:10
Syndicate
Mersana Therapeutics 5M share IPO priced at $15.00 »

The deal priced in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

BLUE

bluebird bio

$106.90

-4.2 (-3.78%)

21:09
06/27/17
06/27
21:09
06/27/17
21:09
Syndicate
bluebird bio 3.81M share Secondary priced at $105.00 »

Goldman Sachs,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

ADNT

Adient

$63.20

-1.63 (-2.51%)

20:25
06/27/17
06/27
20:25
06/27/17
20:25
Conference/Events
Adient to hold a meeting »

EVP & CFO Stafeil,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jul

GIS

General Mills

$55.52

-0.65 (-1.16%)

, MON

Monsanto

$117.25

-0.55 (-0.47%)

20:25
06/27/17
06/27
20:25
06/27/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

GIS

General Mills

$55.52

-0.65 (-1.16%)

MON

Monsanto

$117.25

-0.55 (-0.47%)

PAYX

Paychex

$58.62

-0.62 (-1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 12

    Jul

AAPL

Apple

$143.73

-2.09 (-1.43%)

19:32
06/27/17
06/27
19:32
06/27/17
19:32
Periodicals
Apple looks to hire 'Siri Event Maven,' 9to5Mac reports »

An Apple job listing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOSBF

Toshiba, also use TOSYY

$2.60

-0.09 (-3.35%)

, TOSYY

Toshiba, also use TOSBF

$15.67

-0.24 (-1.51%)

19:22
06/27/17
06/27
19:22
06/27/17
19:22
Periodicals
Toshiba to face holder wrath after failing to sell chip unit, Reuters says »

Toshiba is anticipated to…

TOSBF

Toshiba, also use TOSYY

$2.60

-0.09 (-3.35%)

TOSYY

Toshiba, also use TOSBF

$15.67

-0.24 (-1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$150.58

-3.01 (-1.96%)

19:21
06/27/17
06/27
19:21
06/27/17
19:21
Periodicals
Facebook previously explored effort to promote flu shots, CNBC reports »

Facebook was working with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

AAPL

Apple

$143.73

-2.09 (-1.43%)

19:15
06/27/17
06/27
19:15
06/27/17
19:15
Hot Stocks
Munster lays out five-year Apple model, sees 'Apple Glasses' wearable in 2020 »

Gene Munster, a longtime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

, GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

19:02
06/27/17
06/27
19:02
06/27/17
19:02
Hot Stocks
Senator urges FTC oversight of Google in wake of Europe fine »

Senator Richard…

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

APO

Apollo Global

$25.90

-0.33 (-1.26%)

18:58
06/27/17
06/27
18:58
06/27/17
18:58
Periodicals
Apollo Global hits record-breaking $23.5B target for buyout fund, WSJ says »

Private equity firm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$55.43

-1.13 (-2.00%)

18:54
06/27/17
06/27
18:54
06/27/17
18:54
Periodicals
Judge says FTC suit against Qualcomm can proceed, Reuters reports »

A federal judge ruled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNEGY

Linde

$19.25

0.08 (0.42%)

18:53
06/27/17
06/27
18:53
06/27/17
18:53
Periodicals
Linde unit agrees to $20M settlement deal in whistleblower case, Reuters says »

Linde's Lincare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCHC

HC2 Holdings

$5.82

0.03 (0.52%)

18:50
06/27/17
06/27
18:50
06/27/17
18:50
Hot Stocks
HC2 Holdings subsidiary to acquire major interest in DTVA »

HC2 Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$65.54

-0.38 (-0.58%)

18:38
06/27/17
06/27
18:38
06/27/17
18:38
Periodicals
Merck's cholesterol drug anacetrapib could serve as catalyst, Barron's reports »

Merck announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

TROX

Tronox

$13.52

-0.25 (-1.82%)

18:37
06/27/17
06/27
18:37
06/27/17
18:37
Hot Stocks
Tronox elects Kaufthal as non-executive chairman »

Tronox announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANCUF

Alimentation Couche-Tard

$49.16

1.0803 (2.25%)

, CST

CST Brands

$48.53

-0.01 (-0.02%)

18:19
06/27/17
06/27
18:19
06/27/17
18:19
Hot Stocks
Alimentation Couche-Tard cleared in Canada for acquisition of CST Brands »

Alimentation Couche-Tard…

ANCUF

Alimentation Couche-Tard

$49.16

1.0803 (2.25%)

CST

CST Brands

$48.53

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSLI

Merus Labs

$1.23

-0.0015 (-0.12%)

18:01
06/27/17
06/27
18:01
06/27/17
18:01
Hot Stocks
Merus Labs reminds shareholders to vote for arrangement with Norgine »

Merus Labs International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIGI

Endurance

$8.20

-0.15 (-1.80%)

18:01
06/27/17
06/27
18:01
06/27/17
18:01
Hot Stocks
Endurance chief administration officer Andreasen to leave company »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$186.97

0.68 (0.37%)

17:41
06/27/17
06/27
17:41
06/27/17
17:41
Hot Stocks
Huntington Ingalls receives contract modifications to incorporate upgrades »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IP

International Paper

$56.18

-0.55 (-0.97%)

17:34
06/27/17
06/27
17:34
06/27/17
17:34
Hot Stocks
International Paper agrees to settle Kleen Products class action litigation »

International Paper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUSA

Houston American Energy

$0.67

0.0385 (6.10%)

17:33
06/27/17
06/27
17:33
06/27/17
17:33
Syndicate
Houston American Energy requests withdrawal of registration statement »

The company determined…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$22.82

0.04 (0.18%)

, RYI

Ryerson

$9.00

-0.1 (-1.10%)

17:24
06/27/17
06/27
17:24
06/27/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: KB…

KBH

KB Home

$22.82

0.04 (0.18%)

RYI

Ryerson

$9.00

-0.1 (-1.10%)

AVAV

AeroVironment

$32.49

1.52 (4.91%)

CAMP

CalAmp

$19.25

-0.37 (-1.89%)

GMRE

Global Medical REIT

$9.83

0.07 (0.72%)

WLL

Whiting Petroleum

$5.48

0.04 (0.74%)

OAS

Oasis Petroleum

$7.93

0.21 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 03

    Jul

  • 04

    Jul

  • 05

    Jul

  • 28

    Jun

CHKE

Cherokee

17:22
06/27/17
06/27
17:22
06/27/17
17:22
Hot Stocks
Breaking Hot Stocks news story on Cherokee »

Cherokee says announcing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

KBH

KB Home

$22.82

0.04 (0.18%)

17:16
06/27/17
06/27
17:16
06/27/17
17:16
Hot Stocks
KB Home sees Q3 housing revenue $1.08B-$1.15B »

Sees Q3 average selling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

KBH

KB Home

$22.82

0.04 (0.18%)

17:16
06/27/17
06/27
17:16
06/27/17
17:16
Hot Stocks
KB Home raises FY17 housing revenue view to $4.2B-$4.4B from $4B-$4.3B »

Sees FY17 average selling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.